Crinetics Pharmaceuticals EPS - Earnings per Share 2017-2024 | CRNX
- Crinetics Pharmaceuticals EPS for the quarter ending September 30, 2024 was $-0.96, a 4.95% decline year-over-year.
- Crinetics Pharmaceuticals 2023 annual EPS was $-3.69, a 17.14% increase from 2022.
- Crinetics Pharmaceuticals 2022 annual EPS was $-3.15, a 12.5% increase from 2021.
- Crinetics Pharmaceuticals 2021 annual EPS was $-2.8, a 15.7% increase from 2020.
Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.